Global Immunoprotein Diagnostic Testing Market by Technology (Enzyme-Linked Immunoassay, Immunofluorescence Assay, Radioimmunoassay), Immunoprotein Type (C-reactive Protein, Complement System Protein, Immunoglobulin), Application, End-User - Forecast 2024-2030- Product Image

Sale

Global Immunoprotein Diagnostic Testing Market by Technology (Enzyme-Linked Immunoassay, Immunofluorescence Assay, Radioimmunoassay), Immunoprotein Type (C-reactive Protein, Complement System Protein, Immunoglobulin), Application, End-User - Forecast 2024-2030

Report
185 Pages
March 2024
Region: Global
360iResearch™
ID: 5888817

UP TO €846EUR$875USD£725GBP OFF until Dec 31^st 2024

The Immunoprotein Diagnostic Testing Market size was estimated at USD 8.81 billion in 2023, USD 9.41 billion in 2024, and is expected to grow at a CAGR of 6.92% to reach USD 14.07 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Immunoprotein Diagnostic Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Immunoprotein Diagnostic Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Immunoprotein Diagnostic Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Beckman Coulter Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, BioMérieux S.A., Calbiotech, Inc., Danaher Corporation, DiaSorin S.p.A., DiaSys Diagnostic Systems GmbH, Diazyme Laboratories Inc., Enzo Biochem Inc., F. Hoffmann-La Roche AG, Grifols, S.A., Luminex Corporation, Miraca Holdings Inc., Ortho Clinical Diagnostics, QIAGEN N.V., Randox Laboratories Ltd., SERVA Electrophoresis GmbH, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific Inc., and Werfen.

Market Segmentation & Coverage

This research report categorizes the Immunoprotein Diagnostic Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Technology
- Enzyme-Linked Immunoassay
- Immunofluorescence Assay
- Radioimmunoassay
Immunoprotein Type
- C-reactive Protein
- Complement System Protein
- Immunoglobulin
Application
- Allergy Testing
- Autoimmune Disease Testing
- Endocrine Testing
- Infectious Disease Testing
- Oncology Testing
- Toxicology Testing
End-User
- Diagnostic Laboratories
- Hospitals & Clinics
- Research Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Immunoprotein Diagnostic Testing Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Immunoprotein Diagnostic Testing Market?
What are the technology trends and regulatory frameworks in the Immunoprotein Diagnostic Testing Market?
What is the market share of the leading vendors in the Immunoprotein Diagnostic Testing Market?
Which modes and strategic moves are suitable for entering the Immunoprotein Diagnostic Testing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Immunoprotein Diagnostic Testing Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in incidence and prevalence of infectious and chronic diseases
5.1.1.2. Growth in demand for early diagnostic services in emerging economies
5.1.1.3. Rise in diagnostic tests and growing demand for chemiluminescence assay
5.1.2. Restraints
5.1.2.1. High cost of immunoprotein diagnostic tests
5.1.3. Opportunities
5.1.3.1. Technological advancements in immunodiagnostic instruments and the introduction of novel automated systems
5.1.3.2. Ongoing development in the condition-specific assays and tests
5.1.4. Challenges
5.1.4.1. Complex regulatory framework for the approval of immunoprotein diagnostic tests
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Immunoprotein Diagnostic Testing Market, by Technology

6.1. Introduction
6.2. Enzyme-Linked Immunoassay
6.3. Immunofluorescence Assay
6.4. Radioimmunoassay

7. Immunoprotein Diagnostic Testing Market, by Immunoprotein Type

7.1. Introduction
7.2. C-reactive Protein
7.3. Complement System Protein
7.4. Immunoglobulin

8. Immunoprotein Diagnostic Testing Market, by Application

8.1. Introduction
8.2. Allergy Testing
8.3. Autoimmune Disease Testing
8.4. Endocrine Testing
8.5. Infectious Disease Testing
8.6. Oncology Testing
8.7. Toxicology Testing

9. Immunoprotein Diagnostic Testing Market, by End-User

9.1. Introduction
9.2. Diagnostic Laboratories
9.3. Hospitals & Clinics
9.4. Research Institutes

10. Americas Immunoprotein Diagnostic Testing Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Immunoprotein Diagnostic Testing Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Immunoprotein Diagnostic Testing Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Abcam PLC
14.1.3. Beckman Coulter Inc.
14.1.4. Becton, Dickinson and Company
14.1.5. Bio-Rad Laboratories Inc.
14.1.6. Bio-Techne Corporation
14.1.7. BioMérieux S.A.
14.1.8. Calbiotech, Inc.
14.1.9. Danaher Corporation
14.1.10. DiaSorin S.p.A.
14.1.11. DiaSys Diagnostic Systems GmbH
14.1.12. Diazyme Laboratories Inc.
14.1.13. Enzo Biochem Inc.
14.1.14. F. Hoffmann-La Roche AG
14.1.15. Grifols, S.A.
14.1.16. Luminex Corporation
14.1.17. Miraca Holdings Inc.
14.1.18. Ortho Clinical Diagnostics
14.1.19. QIAGEN N.V.
14.1.20. Randox Laboratories Ltd.
14.1.21. SERVA Electrophoresis GmbH
14.1.22. Siemens Healthineers
14.1.23. Sysmex Corporation
14.1.24. Thermo Fisher Scientific Inc.
14.1.25. Werfen
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET RESEARCH PROCESS
FIGURE 2. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET DYNAMICS
FIGURE 7. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 8. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2023 VS 2030 (%)
FIGURE 10. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 6. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 10. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY C-REACTIVE PROTEIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COMPLEMENT SYSTEM PROTEIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ALLERGY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ENDOCRINE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 21. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 39. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. CANADA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 42. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. MEXICO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 61. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 65. INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. INDIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. JAPAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. JAPAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 73. JAPAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. JAPAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. THAILAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. THAILAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 97. THAILAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. THAILAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. DENMARK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. DENMARK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 110. DENMARK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. DENMARK IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. EGYPT IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. EGYPT IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 114. EGYPT IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. EGYPT IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. FINLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. FINLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 118. FINLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. FINLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 122. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. FRANCE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. GERMANY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 134. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. ITALY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. NORWAY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. NORWAY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 146. NORWAY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. NORWAY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. POLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. POLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 150. POLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. POLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. QATAR IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. QATAR IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 154. QATAR IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. QATAR IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 170. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SPAIN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. TURKEY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. TURKEY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 182. TURKEY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. TURKEY IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IMMUNOPROTEIN TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 193. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 194. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Abcam PLC
Beckman Coulter Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories Inc.
Bio-Techne Corporation
BioMérieux S.A.
Calbiotech, Inc.
Danaher Corporation
DiaSorin S.p.A.
DiaSys Diagnostic Systems GmbH
Diazyme Laboratories Inc.
Enzo Biochem Inc.
F. Hoffmann-La Roche AG
Grifols, S.A.
Luminex Corporation
Miraca Holdings Inc.
Ortho Clinical Diagnostics
QIAGEN N.V.
Randox Laboratories Ltd.
SERVA Electrophoresis GmbH
Siemens Healthineers
Sysmex Corporation
Thermo Fisher Scientific Inc.
Werfen

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	185
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 9.41 Billion
Forecasted Market Value ( USD ) by 2030	$ 14.07 Billion
Compound Annual Growth Rate	6.9%
Regions Covered	Global
No. of Companies Mentioned	25

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3263EUR$3,374USD£2,796GBP €3625EUR$3,749USD£3,107GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4133EUR$4,274USD£3,542GBP €4593EUR$4,749USD£3,936GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5004EUR$5,174USD£4,288GBP €5560EUR$5,749USD£4,765GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5874EUR$6,074USD£5,034GBP €6527EUR$6,749USD£5,594GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7615EUR$7,874USD£6,526GBP €8461EUR$8,749USD£7,251GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Immunoprotein Market by Product (C3, C4, Free Light Chains), Application (Allergy Testing, Autoimmune Testing, Infectious Disease Testing), End User - Forecast 2024-2030

Immunoprotein Diagnostic Testing Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

Immunoprotein Diagnostic Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Immunoprotein Diagnostic Testing - Global Strategic Business Report

Immunoprotein Diagnostic Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology

About the Immunoprotein Testing Market